Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tiagabine 10mg tablets
0408010ABAAABAB
|
Tiagabine | Tiagabine | Central Nervous System | 146 |
|
Nozinan 25mg/1ml solution for injection ampoules
0402010L0BBAAAA
|
Nozinan (Parenteral) | Levomepromazine hydrochloride | Central Nervous System | 144 |
|
Manerix 300mg tablets
0403020K0BBABAC
|
Manerix | Moclobemide | Central Nervous System | 143 |
|
Morphine 30mg modified-release granules sachets sugar free
0407020Q0AACPCP
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 143 |
|
Effentora 100microgram buccal tablets
0407020A0BKAABC
|
Effentora | Fentanyl | Central Nervous System | 141 |
|
Levetiracetam 500mg gran for soln sachets sugar free
0408010A0AAAWAW
|
Levetiracetam | Levetiracetam | Central Nervous System | 141 |
|
Perizam 2mg/ml oral suspension
040801060BEAACS
|
Perizam | Clobazam | Central Nervous System | 141 |
|
Reletrans 30micrograms/hour transdermal patches
0407020B0BKAFAM
|
Reletrans | Buprenorphine | Central Nervous System | 141 |
|
Levomepromazine hydrochloride 25mg/5ml soln sugar free
0402010L0AAAEAE
|
Levomepromazine hydrochloride | Levomepromazine hydrochloride | Central Nervous System | 140 |
|
Paracetamol 60mg suppositories
0407010H0AACWCW
|
Paracetamol | Paracetamol | Central Nervous System | 140 |
|
Quetiapine 25mg/5ml oral suspension
0402010ABAABDBD
|
Quetiapine | Quetiapine | Central Nervous System | 140 |
|
Abilify 1mg/ml oral solution
0402010ADBBAGAG
|
Abilify | Aripiprazole | Central Nervous System | 139 |
|
Lorazepam 500micrograms/5ml oral solution
0401020P0AACFCF
|
Lorazepam | Lorazepam | Central Nervous System | 139 |
|
Tilodol SR 100mg tablets
040702040BSAAAC
|
Tilodol SR | Tramadol hydrochloride | Central Nervous System | 139 |
|
Actimorph 20mg orodispersible tablets
0407020Q0BQADGH
|
Actimorph | Morphine sulfate | Central Nervous System | 136 |
|
Piracetam 333.3mg/ml oral solution sugar free
0409030P0AAAAAA
|
Piracetam | Piracetam | Central Nervous System | 136 |
|
Relpax 40mg tablets
0407041AABBABAB
|
Relpax | Eletriptan | Central Nervous System | 135 |
|
Strattera 10mg capsules
0404000S0BBAAAA
|
Strattera | Atomoxetine hydrochloride | Central Nervous System | 135 |
|
Brintellix 5mg tablets
0403040ABBBAAAA
|
Brintellix | Vortioxetine | Central Nervous System | 134 |
|
Mirapexin 3.15mg modified-release tablets
0409010W0BBAIAI
|
Mirapexin | Pramipexole | Central Nervous System | 134 |
|
Lamotrigine 10mg/ml oral suspension sugar free
0408010H0AABWBW
|
Lamotrigine | Lamotrigine | Central Nervous System | 133 |
|
Orphenadrine 50mg tablets
0409020N0AAAMAM
|
Orphenadrine hydrochloride | Orphenadrine hydrochloride | Central Nervous System | 133 |
|
Ationdo SR 250mg tablets
0407020AGBCAFAG
|
Ationdo | Tapentadol | Central Nervous System | 132 |
|
Dyzantil 200mg modified-release tablets
0408010W0BKAAAZ
|
Dyzantil | Sodium valproate | Central Nervous System | 132 |
|
Neupro 6mg/24hours transdermal patches
0409010Z0BBACAC
|
Neupro | Rotigotine | Central Nervous System | 131 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.